Risks of blood transfusion - Current incidence data for "quantitative" patient information;Risiken der transfusion von blutkomponenten: Aktuelle anhaltszahlen für eine "quantitative" risikoaufklärung

Anasthesiologie und Intensivmedizin

Volumn 45, Issue 7-8, 2004, Pages 430-434

  Karger, Ralf ^a   Kretschmer, V ^a   Wulf, H ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Blood transfusion; Complications; Patient information; Risks; Side effects

Indexed keywords

BACTERIUM CONTAMINATION; BLOOD; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; FATALITY; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LUNG INJURY; PATIENT INFORMATION; REVIEW; RISK; SCREENING; SEPTICEMIA; TRANSFUSION ASSOCIATED LUNG INJURY; VIRUS TRANSMISSION;

EID: 4344625839     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Kretschmer V, Zeiler T. Aktuelle Aspekte der Transfusionsmedizin. In: Deutsche Akademie für Anästhesiologische Fortbildung (ed.). Refresher Course. Aktuelles Wissen für Anästhesisten. Ebelsbach: Biomed-Verlag; 2002:41-55.
2. Williamson L, Cohen H, Love E, Jones H, Todd A, et al. The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox Sang 2000;78(Suppl.2):291-295.
3. Serious hazards of transfusion (SHOT). http://www.shotuk.org/. Letzter Zugriff am 04.04.2004.
4. Karger R, Kretschmer V. Very low incidence of non-hemolytic febrile transfusion reactions (NHFTR) due to HLA-antibodies in current transfusion policy. Infusionsther Transfusionsmed 1999;26(Suppl. 1):22-
5. Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg 1996;20:1189-1193.
6. DeChristopher PJ, Anderson RR. Risks of transfusion and organ and tissue transplantation. Practical concerns that drive practical policies. Am J Clin Pathol 1997;107(Suppl. 1):S2-S11.
7. Fiebig E. Safety of the blood supply. Clin Orthop 1998;357:6-18.
8. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine - first of two parts: blood transfusion. N Engl J Med 1999;340:438-447.
9. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001;41:997-1000.
10. Shulman IA, Downes KA, Sazama K, Maffei LM. Pretransfusion compatibility testing for red blood cell administration. Curr Opin Hematol 2001;8:397-404.
11. Pineda AA, Vamvakas EC, Gorden LD, Winters JL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999;39:1097-1103.
12. AuBuchon JP, Kruskall MS. Transfusion safety: realigning efforts with risks. Transfusion 1997;37:1211-1216.
13. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15:69-83.
14. Frere MC, Rapaille A, Bouillienne C, Gerard C, Sondag D, et al. [Analysis of 516 reports of reactions after the transfusion of labile blood products]. Transfus Clin Biol 2001;8:333-342.
15. Popovsky MA. Transfusion and lung injury. Transfus Clin Biol 2001;8:272-277.
16. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, et al. Transfusionrelated acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462.
17. Wagner FF, Flegel WA. Transfusionassociated graftversushost disease: risk due to homozygous HLA haplotypes. Transfusion 1995;35:284-291.
18. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41:1493-1499.
19. Blajchman MA, Ali AM, Richardson HL. Bacterial contamination of cellular blood components. Vox Sang 1996;67(Suppl. 3):25-33.
20. Blajchman MA, Goldman M. Bacterial contamination of platelet concentrates: incidence, significance, and prevention. Semin Hematol 2001;38(Suppl. 11):20-26.
21. Depcik-Smith ND, Hay SN, Brecher ME. Bacterial contamination of blood products: factors, options, and insights. J Clin Apheresis 2001;16:192-201.
22. Strong DM, Katz L. Blood-bank testing for infectious diseases: how safe is blood transfusion? TRENDS in Molecular Medicine 2002;8:355-358.
23. Biscoping J, Bein G. Kritische Indikationsstellung beim Einsatz von Blutprodukten im klinischen Alltag. Dt Arztebl 2003;100:A929-A932.
24. Tosti ME, Solinas S, Prati D, Salvaneschi L, Manca M, et al. Anestimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002;117:215-219.
25. Gürtler L. Bloodborne viruses: hepatitis A to G. Semin Thromb Hemost 2002;28(Suppl. 1):31-36.
26. Allain J-P. Emerging viruses in blood transfusion. Vox Sang 2000;78 (Suppl. 2):243-248.
27. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, for the Retrovirus Epidemiology Donor Study. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
28. Siegl G, Cassinotti P. Presence and significance of parvovirus B19 in blood and blood products. Biologicals 1998;26:89-94.
29. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002;42:1019-1026.
30. Schmidt PJ. Syphilis, a disease of direct transfusion. Transfusion 2001;41:1069-1071.
31. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421.
32. Pantanowitz L, Telford SRI, Cannon ME. The impact of babesiosis on transfusion medicine. Transfus Med Rev 2002;16:131-143.
33. Doganay M, Aygen B, Esel D. Brucellosis due to blood transfusion (letter). J Hosp Infect 2001;49:151-152.
34. Al-Kharfy TM. Neonatal brucellosis and blood transfusion: case report and review of the literature. Ann Trop Paediatr 2001;21:349-352.